CX Institutional’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.41M | Sell |
25,985
-12,252
| -32% | -$4.19M | 0.27% | 84 |
|
|
2026
Q1 | $13.5M | Sell |
38,237
-958
| -2% | -$342K | 0.41% | 50 |
|
|
2025
Q4 | $12.8M | Sell |
39,195
-1,765
| -4% | -$560K | 0.38% | 53 |
|
|
2025
Q3 | $11.6M | Buy |
40,960
+3,590
| +10% | +$1.04M | 0.35% | 58 |
|
|
2025
Q2 | $10.4M | Buy |
37,370
+344
| +0.9% | +$97.5K | 0.36% | 52 |
|
|
2025
Q1 | $11.5M | Sell |
37,026
-3,410
| -8% | -$1.01M | 0.44% | 55 |
|
|
2024
Q4 | $10.5M | Buy |
40,436
+81
| +0.2% | +$24K | 0.42% | 53 |
|
|
2024
Q3 | $13M | Buy |
40,355
+30,741
| +320% | +$10.1M | 0.58% | 50 |
|
|
2024
Q2 | $3M | Sell |
9,614
-25,144
| -72% | -$7.39M | 0.14% | 167 |
|
|
2024
Q1 | $9.88M | Buy |
34,758
+13,241
| +62% | +$3.87M | 0.48% | 58 |
|
|
2023
Q4 | $6.2M | Sell |
21,517
-7,699
| -26% | -$2.1M | 0.33% | 82 |
|
|
2023
Q3 | $7.85M | Buy |
29,216
+1,794
| +7% | +$448K | 0.43% | 66 |
|
|
2023
Q2 | $6.09M | Buy |
27,422
+401
| +1% | +$93K | 0.32% | 87 |
|
|
2023
Q1 | $6.59M | Buy |
27,021
+4,486
| +20% | +$1.1M | 0.35% | 78 |
|
|
2022
Q4 | $5.92M | Buy |
22,535
+2,413
| +12% | +$647K | 0.36% | 69 |
|
|
2022
Q3 | $4.54M | Buy |
20,122
+9,320
| +86% | +$2.26M | 0.31% | 84 |
|
|
2022
Q2 | $2.63M | Sell |
10,802
-7,716
| -42% | -$1.89M | 0.2% | 129 |
|
|
2022
Q1 | $4.48M | Sell |
18,518
-3,802
| -17% | -$874K | 0.36% | 77 |
|
|
2021
Q4 | $5.02M | Buy |
22,320
+7,659
| +52% | +$1.62M | 0.4% | 70 |
|
|
2021
Q3 | $3.12M | Sell |
14,661
-285
| -2% | -$65.6K | 0.25% | 101 |
|
|
2021
Q2 | $3.64M | Sell |
14,946
-405
| -3% | -$99.6K | 0.3% | 92 |
|
|
2021
Q1 | $3.82M | Sell |
15,351
-10,631
| -41% | -$2.54M | 0.34% | 90 |
|
|
2020
Q4 | $5.97M | Sell |
25,982
-1,852
| -7% | -$427K | 0.58% | 44 |
|
|
2020
Q3 | $7.07M | Buy |
27,834
+3,403
| +14% | +$843K | 0.76% | 35 |
|
|
2020
Q2 | $5.76M | Buy |
24,431
+1,351
| +6% | +$308K | 0.76% | 30 |
|
|
2020
Q1 | $4.68M | Buy |
23,080
+6,716
| +41% | +$1.47M | 0.76% | 31 |
|
|
2019
Q4 | $3.94M | Buy |
16,364
+54
| +0.3% | +$11.9K | 0.69% | 36 |
|
|
2019
Q3 | $3.16M | Buy |
16,310
+3,734
| +30% | +$717K | 0.51% | 49 |
|
|
2019
Q2 | $2.32M | Buy |
12,576
+6,390
| +103% | +$1.14M | 0.37% | 67 |
|
|
2019
Q1 | $1.18M | Sell |
6,186
-1
| -0% | -$191 | 0.21% | 119 |
|
|
2018
Q4 | $1.2M | Sell |
6,187
-1,154
| -16% | -$225K | 0.25% | 82 |
|
|
2018
Q3 | $1.52M | Buy |
7,341
+288
| +4% | +$56.8K | 0.5% | 57 |
|
|
2018
Q2 | $1.3M | Buy |
+7,053
| New | +$1.25M | 0.48% | 62 |
|
Other funds holding AMGN
CX Institutional's AMGN Position: Q2 2026 in Review
CX Institutional reduced its Amgen (AMGN) stake by 32% in Q2 2026, selling an estimated $4.19M and leaving 25,985 shares worth $9.41M. The position accounts for 0.27% of the portfolio, ranked #84.
CX Institutional first reported a position in AMGN in Q2 2018 and has held it in 33 quarters since. The position peaked at $13.5M in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- CX Institutional held 25,985 shares of Amgen worth $9.41M as of Q2 2026.
- CX Institutional sold 12,252 Amgen shares in Q2 2026, an estimated $4.19M.
- Amgen made up 0.27% of CX Institutional's portfolio in Q2 2026, its #84 holding.
- CX Institutional first reported a position in Amgen in Q2 2018 and has held it in 33 quarters since.
- CX Institutional's Amgen position peaked at $13.5M in Q1 2026.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.